Advertisement
Screener

AIM IMMUNOTECH INC. (AIM) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

1.5 / 5 stars · 24/82 Roast Me

AIM IMMUNOTECH INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

AIM IMMUNOTECH INC. (AIM) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 4.31 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-03-27

  • AIM IMMUNOTECH INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2019-09-30 was 5.89M shares, a 56050.93% increase year-over-year.
  • AIM IMMUNOTECH INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2019-03-31 was 71.86M shares, a 547.05% increase year-over-year.
  • AIM IMMUNOTECH INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2018-09-30 was 10.49K shares, a 99.82% decline year-over-year.
  • AIM IMMUNOTECH INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2018-03-31 was 11.11M shares, a 2.06% increase year-over-year.
  • AIM IMMUNOTECH INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 4.31M shares, a 1991.45% increase from fiscal 2024.
  • AIM IMMUNOTECH INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 205.88K shares, a 94.16% decline from fiscal 2023.
  • AIM IMMUNOTECH INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 3.52M shares, a 18.79% increase from fiscal 2022.
  • AIM IMMUNOTECH INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 2.97M shares, a 37.97% increase from fiscal 2021.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed
2025-12-314.31M shares
10-K · filed 2026-03-27
2024-12-31205.88K shares
10-K · filed 2026-03-27		20.59M shares
10-K · filed 2025-03-27
2023-12-313.52M shares
10-K · filed 2025-03-27
2022-12-312.97M shares
10-K · filed 2024-04-01
2021-12-312.15M shares
10-K · filed 2023-03-31
2020-12-31548.37K shares
10-K · filed 2022-03-31
2019-12-318.35M shares
10-K · filed 2021-03-31
2019-09-305.89M shares
10-Q · filed 2019-11-14		6.73M shares
10-Q · filed 2019-11-14
2019-03-3171.86M shares
10-Q · filed 2019-05-15
2018-12-3122.05M shares
10-K · filed 2019-04-01
2018-09-3010.49K shares
10-Q · filed 2019-11-14		462.36K shares
10-Q · filed 2018-11-14		474.22K shares
10-Q · filed 2019-11-14		20.87M shares
10-Q · filed 2018-11-14
2018-06-3020.40M shares
10-Q · filed 2018-08-14
2018-03-3111.11M shares
10-Q · filed 2019-05-15
2017-12-319.37M shares
10-K · filed 2019-04-01
2017-09-305.97M shares
10-Q · filed 2018-11-14		9.39M shares
10-Q · filed 2018-11-14
2017-06-3018.50M shares
10-Q · filed 2018-08-14
2017-03-3110.88M shares
10-Q · filed 2018-05-15
2016-12-314.03M shares
10-K · filed 2018-03-30
2016-09-304.13M shares
10-Q · filed 2016-11-14
2016-06-3018.81M shares
10-Q · filed 2016-08-15
2016-03-3115.50M shares
10-Q · filed 2016-05-16
2015-12-311.32M shares
10-K · filed 2018-03-30		15.79M shares
10-K · filed 2016-03-29
2015-09-301.42M shares
10-Q · filed 2016-11-14		17.08M shares
10-Q · filed 2015-11-16
2015-06-3017.23M shares
10-Q · filed 2016-08-15
2015-03-3117.32M shares
10-Q · filed 2016-05-16
2014-12-311.46M shares
10-K · filed 2017-03-31		17.49M shares
10-K · filed 2015-03-19
2014-09-3023.49M shares
10-Q · filed 2015-11-16		58.13M shares
10-Q · filed 2014-11-07
2014-06-3023.73M shares
10-Q · filed 2015-08-12		62.58M shares
10-Q · filed 2014-08-08
2014-03-3126.97M shares
10-Q · filed 2015-05-12		72.03M shares
10-Q · filed 2014-05-09
2013-12-3127.97M shares
10-K · filed 2016-03-29		87.50M shares
10-K · filed 2014-03-14
2013-09-3038.42M shares
10-Q · filed 2014-11-07
2013-06-3037.07M shares
10-Q · filed 2014-08-08
2013-03-3136.05M shares
10-Q · filed 2014-05-09
2012-12-3124.20M shares
10-K · filed 2015-03-19		34.70M shares
10-K · filed 2013-03-18
2012-09-309.36M shares
10-Q · filed 2012-11-02		33.35M shares
10-Q · filed 2013-11-08
2012-06-3023.99M shares
10-Q · filed 2013-08-09
2012-03-3154.06M shares
10-Q · filed 2013-05-08
2011-12-3154.24M shares
10-K · filed 2014-03-14
2011-09-30565.41K shares
10-Q · filed 2012-11-02		53.81M shares
10-Q · filed 2012-11-02
2011-06-3053.24M shares
10-Q · filed 2012-08-08
2010-12-3152.80M shares
10-K · filed 2013-03-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CURIS INC (CRIS)United States$0.002B-0.05
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Silexion Therapeutics Corp (SLXN)$0.001B
Advertisement